Keywise Capital Management Limited

Established in 2006, Keywise Capital Management Limited is a Hong Kong-based private equity firm with research offices in Shanghai and Beijing. The firm is licensed by the Hong Kong Securities and Futures Commission, registered with the U.S. SEC, and approved by the Chinese CSRC as a qualified foreign institutional investor. Keywise Capital primarily serves institutional investors, including sovereign wealth funds, endowments, pension funds, and foundations. The firm emphasizes a fundamental, bottom-up stock selection investment approach and is committed to ESG standards, having joined the UN Principles for Responsible Investment in 2020. Keywise operates with a sizable on-the-ground research team and is known for its institutionalized platform.

Keywise Capital focuses on investments in the technology and healthcare sectors, targeting early-stage to pre-IPO companies. The firm's investment strategy includes buyouts and growth-stage investments, with a geographical focus on China, Hong Kong, Taiwan, and Singapore. Keywise Capital has a diverse portfolio, including companies in financial services, FinTech, information technology, machine learning, robotics, manufacturing, market research, and technical support. The firm has a history of leading investments and has achieved exits in its portfolio companies.

Keywise Capital's commitment to ESG principles reflects its dedication to responsible investing. The firm's substantial assets under management and its institutionalized platform underscore its position in the private equity landscape. Keywise Capital's focus on Asia, particularly Greater China, aligns with its expertise in the region's markets and its strategic investment approach.